These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12082838)

  • 1. [Treatment of chronic hepatitis C].
    Bell H; Dalgard O; Bjøro K; Hellum KB; Myrvang B
    Tidsskr Nor Laegeforen; 2002 Apr; 122(9):926-8. PubMed ID: 12082838
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387
    [No Abstract]   [Full Text] [Related]  

  • 3. [New therapeutic possibilities in chronic hepatitis C].
    Criblez DH
    Praxis (Bern 1994); 2000 Mar; 89(11):450-3. PubMed ID: 10758732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C.
    Tinè F; Graviano D; Giannuoli G; Madonia S; Malizia G; Patti S; Fasola S; Cottone M; D'Amico G;
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1113-23. PubMed ID: 20848397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of chronic hepatitis C].
    Ferenci P
    Wien Med Wochenschr; 2000; 150(23-24):481-5. PubMed ID: 11205179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peginterferon and ribavirin for hepatitis C.
    Evoli A; Servidei S
    N Engl J Med; 2007 Mar; 356(12):1269-70; author reply 1271. PubMed ID: 17380575
    [No Abstract]   [Full Text] [Related]  

  • 8. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
    Papastathopoulos K; Bouzas E; Naoum G; Vergados I; Tsiodras S
    J Infect; 2006 Feb; 52(2):e59-61. PubMed ID: 15951019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.
    Behnam SE; Hindiyeh R; Fife DJ; Jeffes EW; Wu JJ
    Clin Exp Dermatol; 2010 Jun; 35(4):397-8. PubMed ID: 19663835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus infection.
    Himelhoch S
    N Engl J Med; 2001 Nov; 345(19):1426-7; author reply 1427-8. PubMed ID: 11794184
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.
    Soza A; Hoofnagle JH
    Hepatology; 2003 Jul; 38(1):267. PubMed ID: 12830010
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon-ribavirin-associated ischemic colitis.
    Punnam SR; Pothula VR; Gourineni N; Punnam A; Ranganathan V
    J Clin Gastroenterol; 2008 Mar; 42(3):323-5. PubMed ID: 18223489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
    Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pegylated interferon-alpha for the treatment of chronic hepatitis C].
    Weis NM; Krarup HB; Skinhøj P
    Ugeskr Laeger; 2003 Oct; 165(44):4211-5. PubMed ID: 14621552
    [No Abstract]   [Full Text] [Related]  

  • 16. [Peginterferon alpha combined with ribavirin for the treatment of chronic hepatitis C].
    Xu Y; Wang JB
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):415-6. PubMed ID: 22053369
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?].
    Larrey D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B283-90. PubMed ID: 12180302
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.
    Adinolfi LE; Durante Mangoni E; Andreana A
    Am J Gastroenterol; 2001 Feb; 96(2):607-8. PubMed ID: 11232725
    [No Abstract]   [Full Text] [Related]  

  • 19. The adjuvant role of thyroxine in the treatment of chronic hepatitis C infection.
    Tran HA; Ianna EA; Jones TL; Reeves GE
    QJM; 2012 Jul; 105(7):683-7. PubMed ID: 21690180
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.